{ "tag": [ "compiled" ], "id": "ocds-r6ebe6-0000480471-2017-06-09T00:00:00Z", "date": "2017-06-09T00:00:00Z", "ocid": "ocds-r6ebe6-0000480471", "initiationType": "tender", "parties": [ { "id": "org-3", "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")", "identifier": { "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")" }, "address": { "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent", "locality": "Edinburgh", "region": "UKM", "postalCode": "EH12 9EB" }, "contactPoint": { "name": "Hazel Johnstone", "email": "hazel.johnstone@nhs.net", "telephone": "+44 1698794561", "url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.htmlh" }, "roles": [ "buyer", "centralPurchasingBody", "reviewBody" ], "details": { "classifications": [ { "id": "Body governed by public law", "scheme": "TED_CA_TYPE" }, { "id": "07", "description": "Health", "scheme": "COFOG" } ], "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/" } }, { "id": "org-4", "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")", "identifier": { "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")" }, "address": { "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent", "locality": "Edinburgh", "region": "UKM", "postalCode": "EH12 9EB" }, "contactPoint": { "name": "Stuart Gillespie", "email": "stuart.gillespie@nhs.net", "telephone": "+44 1698794585", "url": "http://" }, "roles": [ "buyer", "centralPurchasingBody", "reviewBody" ], "details": { "classifications": [ { "id": "Body governed by public law", "scheme": "TED_CA_TYPE" }, { "id": "07", "description": "Health", "scheme": "COFOG" } ], "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/" } } ], "buyer": { "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")", "id": "org-4" }, "tender": { "id": "NP34917", "title": "Supply of Anti D, Four Factor Concentrate and Hyper Immunes (AFHP)", "description": "Supply of Anti D, Four Factor Concentrate and Hyper Immunes (AFHP). This Framework Agreement has been awarded in seven (7) categories, each of which is identified as a \"Lot\" as detailed in the contract notice. The Lots are as follows:- Lot 1 - Anti-D (Rho) Immunoglobulin Lot 2 - HBIG Hepatitis B Immunoglobulin Intramuscular use (IM) Lot 3 - HBIG Hepatitis B Immunoglobulin intravenous use (IV) Lot 4 - HTIG Tetanus immunoglobulin intramuscular use (IM) Lot 5 - Anti Rabies immunoglobulin for intramuscular use (IM) Lot 6 - VZIG Varicella - Zoster immunoglobulin intramuscular (IM) Lot 7 - Coagulation Factor Four Factor Prothrombin Complex Concentrate (PCC) All deliveries under the framework agreement will be to one central location, namely 'The Scottish National Blood Transfusion Service' (SNBTS), Edinburgh.", "status": "complete", "items": [ { "id": "2", "additionalClassifications": [ { "id": "33141520", "scheme": "CPV" } ], "deliveryLocation": { "description": "Scottish National Blood Transfusion Service (SNBTS), Edinburgh" }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "2" }, { "id": "3", "additionalClassifications": [ { "id": "33141520", "scheme": "CPV" } ], "deliveryLocation": { "description": "Scottish National Blood Transfusion Service (SNBTS), Edinburgh" }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "3" }, { "id": "4", "additionalClassifications": [ { "id": "33141520", "scheme": "CPV" } ], "deliveryLocation": { "description": "Scottish National Blood Transfusion Service (SNBTS), Edinburgh" }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "4" }, { "id": "5", "additionalClassifications": [ { "id": "33141520", "scheme": "CPV" } ], "deliveryLocation": { "description": "Scottish National Blood Transfusion Service (SNBTS), Edinburgh" }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "5" }, { "id": "6", "additionalClassifications": [ { "id": "33141520", "scheme": "CPV" } ], "deliveryLocation": { "description": "Scottish National Blood Transfusion Service (SNBTS), Edinburgh" }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "6" }, { "id": "7", "additionalClassifications": [ { "id": "33141520", "scheme": "CPV" } ], "deliveryLocation": { "description": "Scottish National Blood Transfusion Service (SNBTS), Edinburgh" }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "7" }, { "id": "1", "additionalClassifications": [ { "id": "33141510", "scheme": "CPV" } ], "deliveryLocation": { "description": "Scottish National Blood Transfusion Service (SNBTS), Edinburgh" }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "1" } ], "value": { "amount": 8000000, "currency": "GBP" }, "procurementMethod": "open", "procurementMethodDetails": "Open procedure", "mainProcurementCategory": "goods", "submissionMethod": [ "electronicSubmission" ], "submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html", "tenderPeriod": { "endDate": "2017-03-27T12:00:00Z" }, "awardPeriod": { "startDate": "2017-03-27T12:00:00Z" }, "documents": [ { "id": "FEB274757", "documentType": "contractNotice", "title": "Supply of Anti D, Four Factor Concentrate and Hyper Immunes (AFHP)", "description": "This Framework Agreement is for the supply of Anti D, Four Factor Concentrate and Hyper Immunes (AFHP). The Goods have been split into seven (7) categories, each of which is identified as a \"Lot\". The Lots are as follows:- Lot 1 - Anti-D (Rho) Immunoglobulin Lot 2 - HBIG Hepatitis B Immunoglobulin Intramuscular use (IM) Lot 3 - HBIG Hepatitis B Immunoglobulin intravenous use (IV) Lot 4 - HTIG Tetanus immunoglobulin intramuscular use (IM) Lot 5 - Anti Rabies immunoglobulin for intramuscular use (IM) Lot 6 - VZIG Varicella - Zoster immunoglobulin intramuscular Lot 7 - Coagulation Factor Four Factor Prothrombin Complex Concentrate (PCC) All deliveries under the framework agreement will be to one central location, namely 'The Scottish National Blood Transfusion Service' (SNBTS), Edinburgh.", "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB274757", "format": "text/html" }, { "id": "JUN285759", "documentType": "awardNotice", "title": "Supply of Anti D, Four Factor Concentrate and Hyper Immunes (AFHP)", "description": "Supply of Anti D, Four Factor Concentrate and Hyper Immunes (AFHP). This Framework Agreement has been awarded in seven (7) categories, each of which is identified as a \"Lot\" as detailed in the contract notice. The Lots are as follows:- Lot 1 - Anti-D (Rho) Immunoglobulin Lot 2 - HBIG Hepatitis B Immunoglobulin Intramuscular use (IM) Lot 3 - HBIG Hepatitis B Immunoglobulin intravenous use (IV) Lot 4 - HTIG Tetanus immunoglobulin intramuscular use (IM) Lot 5 - Anti Rabies immunoglobulin for intramuscular use (IM) Lot 6 - VZIG Varicella - Zoster immunoglobulin intramuscular (IM) Lot 7 - Coagulation Factor Four Factor Prothrombin Complex Concentrate (PCC) All deliveries under the framework agreement will be to one central location, namely 'The Scottish National Blood Transfusion Service' (SNBTS), Edinburgh.", "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN285759", "format": "text/html" } ], "lots": [ { "id": "2", "title": "HBIG Hepatitis B Immunoglobulin intramuscular use (IM)", "description": "Supply of HBIG Hepatitis B Immunoglobulin intramuscular use (IM)", "status": "complete", "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) separate periods of up to twelve (12) months by giving a minimum of three (3) months written notice of such extension." } }, { "id": "3", "title": "HBIG Hepatitis B Immunoglobulin intravenous use (IV)", "description": "Supply of HBIG Hepatitis B Immunoglobulin intravenous use (IV)", "status": "complete", "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) separate periods of up to twelve (12) months by giving a minimum of three (3) months written notice of such extension." } }, { "id": "4", "title": "HTIG Tetanus immunoglobulin intramuscular use (IM)", "description": "Supply of HTIG Tetanus immunoglobulin intramuscular use (IM)", "status": "complete", "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) separate periods of up to twelve (12) months by giving a minimum of three (3) months written notice of such extension." } }, { "id": "5", "title": "Anti Rabies immunoglobulin for intramuscular use (IM)", "description": "Supply of Anti Rabies immunoglobulin for intramuscular use (IM)", "status": "complete", "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) separate periods of up to twelve (12) months by giving a minimum of three (3) months written notice of such extension." } }, { "id": "6", "title": "VZIG Varicella - Zoster immunoglobulin intramuscular use (IM)", "description": "Supply of VZIG Varicella - Zoster immunoglobulin intramuscular use (IM)", "status": "complete", "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) separate periods of up to twelve (12) months by giving a minimum of three (3) months written notice of such extension." } }, { "id": "7", "title": "Coagulation Factor Four Factor Prothrombin Complex Concentrate (PCC)", "description": "Supply of Coagulation Factor Four Factor Prothrombin Complex Concentrate (PCC) in a range of vials.", "status": "complete", "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) separate periods of up to twelve (12) months by giving a minimum of three (3) months written notice of such extension." } }, { "id": "1", "title": "Anti-D (Rho) Immunoglobulin", "description": "Supply of Anti-D (Rho) Immunoglobulin either in a pre-filled syringe or vial.", "status": "complete", "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) separate periods of up to twelve (12) months by giving a minimum of three (3) months written notice of such extension." } } ], "lotDetails": { "maximumLotsBidPerSupplier": 2147483647 }, "bidOpening": { "date": "2017-03-27T12:00:00Z" }, "contractTerms": { "hasElectronicPayment": true, "hasElectronicOrdering": true, "electronicInvoicingPolicy": "allowed" }, "coveredBy": [ "GPA" ], "selectionCriteria": { "criteria": [ { "type": "suitability", "description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015." }, { "type": "technical", "description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.", "minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes." } ] }, "submissionTerms": { "languages": [ "en" ], "bidValidityPeriod": { "durationInDays": 90 } }, "techniques": { "hasFrameworkAgreement": true, "frameworkAgreement": { "maximumParticipants": 6 } }, "classification": { "id": "33600000", "scheme": "CPV" }, "reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.", "hasRecurrence": false }, "language": "EN", "description": "The total value referred to in this notice covers the initial twenty-four (24) months duration of the Framework Agreement and the full twenty-four (24) months extension options. (SC Ref:497190)", "links": [ { "rel": "canonical", "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000480471" }, { "rel": "canonical", "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000480471" } ], "noticetype": "OJEU - F3 - Contract Award Notice", "awards": [ { "id": "NP34917-1", "title": "Anti-D (Rho) Immunoglobulin", "relatedLots": [ "1" ] }, { "id": "NP34917-2", "title": "HBIG Hepatitis B Immunoglobulin intramuscular use (IM)", "relatedLots": [ "2" ] }, { "id": "NP34917-3", "title": "HBIG Hepatitis B Immunoglobulin intravenous use (IV)", "relatedLots": [ "3" ] }, { "id": "NP34917-4", "title": "HTIG Tetanus immunoglobulin intramuscular use (IM)", "relatedLots": [ "4" ] }, { "id": "NP34917-5", "title": "Anti Rabies immunoglobulin for intramuscular use (IM)", "relatedLots": [ "5" ] }, { "id": "NP34917-6", "title": "VZIG Varicella - Zoster immunoglobulin intramuscular use (IM)", "relatedLots": [ "6" ] }, { "id": "NP34917-7", "title": "Coagulation Factor Four Factor Prothrombin Complex Concentrate (PCC)", "relatedLots": [ "7" ] } ], "contracts": [ { "id": "NP34917-1", "awardID": "NP34917-1", "title": "Anti-D (Rho) Immunoglobulin", "status": "active", "dateSigned": "2017-05-17T00:00:00Z" }, { "id": "NP34917-2", "awardID": "NP34917-2", "title": "HBIG Hepatitis B Immunoglobulin intramuscular use (IM)", "status": "active", "dateSigned": "2017-05-17T00:00:00Z" }, { "id": "NP34917-3", "awardID": "NP34917-3", "title": "HBIG Hepatitis B Immunoglobulin intravenous use (IV)", "status": "active", "dateSigned": "2017-05-17T00:00:00Z" }, { "id": "NP34917-4", "awardID": "NP34917-4", "title": "HTIG Tetanus immunoglobulin intramuscular use (IM)", "status": "active", "dateSigned": "2017-05-17T00:00:00Z" }, { "id": "NP34917-5", "awardID": "NP34917-5", "title": "Anti Rabies immunoglobulin for intramuscular use (IM)", "status": "active", "dateSigned": "2017-05-17T00:00:00Z" }, { "id": "NP34917-6", "awardID": "NP34917-6", "title": "VZIG Varicella - Zoster immunoglobulin intramuscular use (IM)", "status": "active", "dateSigned": "2017-05-17T00:00:00Z" }, { "id": "NP34917-7", "awardID": "NP34917-7", "title": "Coagulation Factor Four Factor Prothrombin Complex Concentrate (PCC)", "status": "active", "dateSigned": "2017-05-17T00:00:00Z" } ], "relatedProcesses": [ { "id": "1", "relationship": [ "planning" ], "scheme": "EU-OJ", "identifier": "2017/S 040-072661" } ] }